COSSH criteria produced a more reasonable epidemiological pyramid-like distribution ... adsorption systems—were used. Renal replacement therapy (RRT) was initiated in cases of hepatorenal ...

A two-drug combination for treating advanced kidney cancer has shown sustained and durable clinical benefit in more than five ...

The U.S. Food and Drug Administration has approved Apellis Pharmaceuticals' Empaveli (pegcetacoplan) as the first treatment ...

Renal transplant is the treatment of choice for most patients with end stage renal disease. Renal transplant involves the transfer a one kidney from a living donor or a brain dead cadaveric donor ...

The FDA has approved Empaveli for the treatment of adult and pediatric patients aged 12 years and older with C3G or primary ...

Identifying early predictors of chronic kidney disease (CKD) progression in patients with lupus nephritis may help define a high-risk group.

PD-1 treatment may help by shifting certain immune cells to fight diseases like kidney cancer; higher CD163-positive TAMs are linked to better outcomes.

Background Chronic kidney disease is common in patients with coronary artery disease (CAD) and can significantly affect drug excretion and efficacy. This study focuses on the effects of modification ...

Kidney stones are common medical condition, however it is not something worrying. If you adhere to some natural remedies consistently at home, kidney stones will pass during urine easily.

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

Shares of ProKidney jump 515% after its kidney cell therapy shows strong efficacy in a Phase II diabetes-related CKD study.